Modulation of DPK cell function by the kappa opioid agonist U50,488H

Adv Exp Med Biol. 1998:437:125-36. doi: 10.1007/978-1-4615-5347-2_14.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / pharmacology*
  • Animals
  • CD4 Antigens
  • CD8 Antigens
  • Cell Line
  • Interleukin-2 / biosynthesis
  • Leukopoiesis / drug effects
  • Leukopoiesis / physiology*
  • Male
  • Mice
  • Receptors, Interleukin-2 / antagonists & inhibitors
  • Receptors, Interleukin-2 / biosynthesis
  • Receptors, Opioid, kappa / agonists
  • Receptors, Opioid, kappa / physiology*
  • T-Lymphocytes / cytology*
  • T-Lymphocytes / drug effects

Substances

  • CD4 Antigens
  • CD8 Antigens
  • Interleukin-2
  • Receptors, Interleukin-2
  • Receptors, Opioid, kappa
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer